Rhizopus Nigricans Mold IgE

If your asthma keeps flaring or your respiratory symptoms have no clear trigger, a mold you've never heard of could be doing quiet damage. Rhizopus nigricans (now reclassified in modern mycology as Rhizopus stolonifer, though the older name persists in allergy testing) is a black bread mold found in damp homes, stored foods, decaying fruit, and many workplaces, and your immune system can react to it the same way it reacts to pollen or dust mites.

This blood test checks whether you have made specific antibodies against this mold. A positive result means your body has become allergically sensitized, which can drive airway inflammation, worsen asthma control, and in rare cases cause a deeper lung condition. Compared with more common molds like Aspergillus, Alternaria, and Cladosporium, Rhizopus is a relatively uncommon sensitizer, but it can be clinically meaningful in humid climates and certain occupational settings, and standard allergy panels often leave it out.

What This Test Measures

The test detects IgE (immunoglobulin E) antibodies in your blood that are aimed specifically at proteins from Rhizopus nigricans. IgE antibodies are made by immune cells called B cells and plasma cells. When you have IgE against a substance, your immune system has learned to treat that substance as a threat and can launch an allergic reaction when you encounter it.

Most IgE in your body is not floating in the blood. It sits attached to mast cells and basophils, the cells that release histamine during allergic reactions. A blood test captures the small fraction that circulates freely, which gives a reliable signal of whether sensitization has occurred. In one pediatric asthma study, children with Rhizopus sensitization also showed shifts in immune-related proteins pointing to eosinophilic and innate immune activity, meaning the antibody is part of a larger allergic process, not an isolated number.

Asthma and Airway Inflammation

The clearest evidence for this marker comes from asthma. In a single-center study of children with allergic asthma in Southwest China (a humid subtropical region), about two out of three (67.3%) were sensitized to Rhizopus nigricans, while none of the healthy children in the comparison group were. Higher Rhizopus IgE tracked with higher total IgE, more blood eosinophils, more airway inflammation measured by exhaled nitric oxide, and worse asthma control scores. This high rate is specific to that population and is not generalizable to allergic asthma worldwide, where Rhizopus sensitization rates are typically much lower.

In a Finnish study of schoolchildren living in damp buildings, mold-specific IgE was uncommon overall (only 4 of 93 children had Rhizopus-specific IgE), but most children who did have it were boys with asthma or wheeze. Carrying mold-specific IgE raised the odds of asthma roughly sixfold in that group, though the small number of positive cases means that estimate is statistically fragile. Many people exposed to mold never develop a measurable antibody response, but those who do tend to have more reactive airways.

Occupational and Environmental Exposure

Some jobs expose you to far more Rhizopus than ordinary life does. Among tobacco-processing workers, Rhizopus-specific IgE was positive in 51.5% of exposed employees, much higher than in unexposed controls. The same workers had more nasal and respiratory symptoms and worse lung function. A documented case in a coal miner showed clear occupational asthma traced specifically to Rhizopus in the mine environment.

Outside of work, exposure often comes from indoor dampness, decaying fruit, and stored foods rather than outdoor air. That is one reason the source of a positive result is not always obvious without some detective work in your living and working spaces.

Allergic Bronchopulmonary Mycosis

In rare cases, sensitization to Rhizopus can progress to a deeper lung condition called allergic bronchopulmonary mycosis, where mold colonizes the airways and drives severe, persistent inflammation. Two siblings (one with cystic fibrosis and one without) were reported with severe asthma-like illness unresponsive to usual treatment until Rhizopus nigricans was identified as the trigger. International guidelines recommend screening for Aspergillus fumigatus sensitization in adults newly diagnosed with asthma at specialist centers and in children with difficult-to-treat asthma; those guidelines do not specifically address Rhizopus, though the same clinical reasoning, that an unidentified fungal trigger may be driving severe airway disease, applies.

Hidden Sensitization Standard Panels Miss

One reason this test matters is that Rhizopus is often left off routine allergy testing. In the Chinese pediatric study, a child first labeled as having nonallergic asthma (after a 19-allergen panel came back negative) turned out to be sensitized to Rhizopus nigricans once it was specifically tested. In that same study population, a very high total IgE level (around 395 kU/L or higher) flagged children likely to be Rhizopus-sensitized. This threshold has not been validated elsewhere and is not a general screening cutoff, but an unexplained high total IgE is a reasonable prompt to consider less common mold allergies.

When Results Can Be Misleading

Specific IgE tests are generally stable, but a few factors can distort how you read the number:

• Total IgE context: age, sex, and a personal allergy profile all shift baseline IgE. Children tend to have higher levels than adults, and females tend to run lower than males. A specific IgE result makes most sense alongside a total IgE for context.
• Sensitization is not the same as allergy: a positive result means your immune system recognizes the mold, but you can be sensitized without having symptoms. Clinical history is what turns a number into a diagnosis.
• Cross-reactivity with other fungi: people allergic to one mold often have antibodies to several. Some of that reflects true multiple allergies; some reflects shared protein structures (such as cyclophilins and proteases) across species.
• Assay differences: different laboratories use different methods and units. A direct comparison only works if your follow-up test uses the same assay platform.
• Anti-IgE biologics: omalizumab raises total serum IgE three- to ten-fold by forming complexes that clear slowly, and it can shift measured allergen-specific IgE values (including negative-to-positive seroconversion on some platforms), so let the lab and your clinician know if you take it.

Why One Reading Is Not the Whole Picture

Specific IgE levels can change over years as exposure, season, and treatment change. A single value tells you whether you are sensitized right now. A trend can show whether your sensitization is climbing, holding steady, or fading. No guidelines define a specific retesting interval for Rhizopus IgE, and detailed studies of within-person variability are lacking, so retesting decisions should be guided by symptoms, exposure changes, and your clinician's judgment rather than a fixed schedule.

Because of that uncertainty, trends paired with symptom records carry more weight than chasing small changes in a single number.

What to Do With an Unexpected Result

A positive Rhizopus IgE is most useful when paired with other findings. If you have asthma, wheeze, chronic cough, or sinus symptoms, consider companion tests: a total IgE for context, a blood eosinophil count, and IgE to common molds like Aspergillus, Alternaria, Cladosporium, and Penicillium to see whether your sensitization is broad or focused. If your asthma is severe or hard to control, a workup for allergic bronchopulmonary mycosis (which involves imaging and additional blood tests) makes sense with an allergist or pulmonologist.

If your result is positive but you feel fine, treat it as information rather than a diagnosis. Look for dampness, water damage, or visible mold in your home and workplace, and bring the result to your clinician if respiratory symptoms appear later. A negative result does not rule out other mold or environmental allergies, especially if your symptoms are clearly seasonal or location-driven.